Loading...

Home
ETF
FDMT

FDMT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

FDMT News

4D Molecular Therapeutics Grants 23,600 RSUs to New Employees

Jan 17 2026Globenewswire

Major Stocks Including BlackBerry, FedEx, and Nike Decline in Friday's Pre-Market Trading

Dec 19 2025Benzinga

4D Molecular Shares Decline Following Initial Trial Results for Cystic Fibrosis Treatment

Dec 17 2025SeekingAlpha

4D Molecular Therapeutics Reports Positive Interim Data for 4D-710 in Cystic Fibrosis Trial

Dec 17 2025Globenewswire

4D Molecular Therapeutics Announces Encouraging Interim Phase 1 Results for 4D-710 in Cystic Fibrosis

Dec 17 2025NASDAQ.COM

4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan

Dec 12 2025Globenewswire

4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan

Dec 12 2025Newsfilter

NovaBridge's Visara Division Names Renowned Ophthalmology Experts as Chief Medical Officer and Chair of Scientific Advisory Board to Advance VIS-101

Nov 21 2025Newsfilter

NovaBridge's Visara Division Names Renowned Ophthalmology Experts as Chief Medical Officer and Chair of Scientific Advisory Board to Advance VIS-101

Nov 20 2025Globenewswire

4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer

Nov 17 2025Yahoo Finance

4DMT Names Kristian Humer as Chief Financial Officer

Nov 17 2025NASDAQ.COM

4DMT Unveils New Employment Incentive Grants

Nov 14 2025Newsfilter

Eli Lilly invests in eye care by acquiring gene therapy company Adverum

Oct 24 2025Reuters

4DMT Unveils New Employment Incentive Grants

Sep 12 2025Newsfilter

SNY's Gene Therapy for Eye Disease Receives FDA Fast Track Designation

Sep 11 2025NASDAQ.COM

4D Molecular Therapeutics, Inc. (FDMT) Participates in Morgan Stanley's 23rd Annual Global Healthcare Conference (Transcript)

Sep 09 2025Newsfilter